Inhibikase Therapeutics Operating Margin Growth & History (IKT)

Inhibikase Therapeutics's operating margin was −7,711.98% for fiscal 2023.

View full Inhibikase Therapeutics company overview

Inhibikase Therapeutics annual operating margin history

Inhibikase Therapeutics annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20232023-12-31−7,711.98%+6974.19 pp
20222022-12-31−14,686.17%−14209.94 pp
20212021-12-31−476.23%−72.71 pp
20202020-12-31−403.52%

Inhibikase Therapeutics operating margin trends

Across the available reported history, Inhibikase Therapeutics's operating margin increased from −14,686.17% to −7,711.98%, a change of +6974.19 percentage points. The latest reported quarter, Q4 2023, shows −440,356,600.00%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Inhibikase Therapeutics filings at SEC.gov ↗